Wantai Biological Pharmacy's share price [SHA: 603392] closed up 1% today after the Chinese pharmaceutical firm said its nine-valent HPV jab Cecolin has been given the greenlight to go to market in China. It will be the second such jab available globally after Merck Sharp & Dohme’s Gardasil.